Skip to main content
Filing year 2023

RARE SISTERS BATTEN FOUNDATION INC

Arvada, Colorado·EIN 84-4406415·NTEE G80 · Diseases, Disorders & Medical Disciplines·501(c)(3)
Total revenue
$284k
Total assets
$142k
Total expenses
$214k
Reported officers
8
Mission

THE RARE SISTERS BATTEN FOUNDATION AIMS TO HELP FURTHER THE DEVELOPMENT OF MEDICAL RESEARCH FOR TREATMENTS AND CURES FOR CLN3 BATTEN DISEASE, AND PROVIDE MONETARY ASSISTANCE TO FAMILIES WITH CHILDREN DIAGNOSED WITH BATTEN DISEASE.

Reported officers (all unpaid)

No paid executives reported in 2023. RARE SISTERS BATTEN FOUNDATION INC reported 8 unpaid officers and board members on its 990.

Board Member
Board Member
Board Member
Secretary
Board Member
President
Board Member
Treasurer

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Sector benchmark

What Diseases, Disorders & Medical Disciplines executives earn

RARE SISTERS BATTEN FOUNDATION INC reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable diseases, disorders & medical disciplines organization nationwide earns a median of $91,250.

25th percentile
$43k
Median
$91,250
75th percentile
$169k
90th percentile
$325k

These are diseases, disorders & medical disciplines sector-wide figures, not this organization's reported pay. Based on 2,397 organizations across 2,397 filings (2021 – 2024).

See full Diseases, Disorders & Medical Disciplines compensation data
FAQ

Common questions about RARE SISTERS BATTEN FOUNDATION INC

What are RARE SISTERS BATTEN FOUNDATION INC's revenue and expenses?

In 2023, RARE SISTERS BATTEN FOUNDATION INC reported $284k in total revenue and $214k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.